|
Status |
Public on Aug 15, 2011 |
Title |
MB231_siRelA_TNF_4h |
Sample type |
RNA |
|
|
Source name |
Breast cancer cell line (MDA-MB-231)
|
Organism |
Homo sapiens |
Characteristics |
cell line: MDA-MB-231 treatment group: siRelA_TNF_4h
|
Treatment protocol |
MDA-MB-231 was transfected with siRNA of negative control, EZH2, RelA, and RelB respectively followed by treatment of 10ng/ml TNFalpha for 4 hours.
|
Growth protocol |
MDA-MB-231 was cultured in were grown in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum and 5000U/mL penicillin/streptomycin (Invitrogen) and maintained at 37 °C with 5% CO2.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was isolated using Trizol (Invitrogen) and purified with the RNeasy Mini Kit (Qiagen).
|
Label |
Cy3
|
Label protocol |
standard Illumina protocol
|
|
|
Hybridization protocol |
standard Illumina protocol
|
Scan protocol |
standard Illumina protocol
|
Description |
siRelA TNF4h
|
Data processing |
Illumina Inc. BeadStudio version 3.2.7; Shift to 75 percentile
|
|
|
Submission date |
Jul 14, 2011 |
Last update date |
Aug 15, 2011 |
Contact name |
Peiyong Guan |
E-mail(s) |
[email protected]
|
Organization name |
Genome Institute of Singapore
|
Street address |
60 Biopolis Street, Genome, #02-01
|
City |
Singapore |
ZIP/Postal code |
138672 |
Country |
Singapore |
|
|
Platform ID |
GPL6104 |
Series (1) |
GSE30670 |
Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers |
|